Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06636682 |
Title | FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
Recruitment | Recruiting |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Cellvax Therapeutics Inc |
Indications | |
Therapies | |
Age Groups: | child | adult | senior |
Covered Countries | USA |